THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $552,147 | -6.0% | 63,980 | +12.8% | 0.00% | 0.0% |
| Q2 2023 | $587,156 | -4.6% | 56,730 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $615,521 | +15.3% | 56,730 | +19.2% | 0.00% | 0.0% |
| Q4 2022 | $533,848 | +111.8% | 47,580 | +91.6% | 0.00% | 0.0% |
| Q3 2022 | $252,000 | +12.0% | 24,830 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $225,000 | -5.1% | 24,830 | 0.0% | 0.00% | – |
| Q1 2022 | $237,000 | -13.5% | 24,830 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $274,000 | +94.3% | 24,830 | +308.3% | 0.00% | – |
| Q1 2020 | $141,000 | -55.2% | 6,081 | -50.0% | 0.00% | -100.0% |
| Q4 2019 | $315,000 | – | 12,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |